18-fluorodeoxyglucose-positron emission tomography (FDG-PET) evaluation of nodular lesions in patients with Neurofibromatosis type 1 and plexiform neurofibromas (PN) or malignant peripheral nerve sheath tumors (MPNST).

Authors

Holly Meany, George Washington University
Eva Dombi
James Reynolds
Millie Whatley
Ambereen Kurwa
Maria Tsokos
Wanda Salzer
Andrea Gillespie
Andrea Baldwin
Joanne Derdak
Brigitte Widemann

Document Type

Journal Article

Publication Date

1-1-2013

Journal

Pediatric blood & cancer

Volume

60

Issue

1

Inclusive Pages

59–64

DOI

10.1002/pbc.24212

Keywords

Adolescent; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Nerve Sheath Neoplasms; Neurofibroma, Plexiform; Neurofibromatosis 1; Positron-Emission Tomography; Radiopharmaceuticals

APA Citation

Meany, H., Dombi, E., Reynolds, J., Whatley, M., Kurwa, A., Tsokos, M., Salzer, W., Gillespie, A., Baldwin, A., Derdak, J., & Widemann, B. (2013). 18-fluorodeoxyglucose-positron emission tomography (FDG-PET) evaluation of nodular lesions in patients with Neurofibromatosis type 1 and plexiform neurofibromas (PN) or malignant peripheral nerve sheath tumors (MPNST).. Pediatric blood & cancer, 60 (1). http://dx.doi.org/10.1002/pbc.24212

Peer Reviewed

1